At least 63 biopharma layoff rounds were conducted in the first quarter of this year, with cell and gene biotechs accounting ...

Healthcare pioneer Laura Shawver, Ph.D. appointed Chair of the Board and industry veteran Roy Baynes M.D., Ph.D. appointed as independent, non-exe ...

Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ...

The University of Medicine and Health Sciences, (UMHS), a small, mission-driven medical school with a commitment to student ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Presented a poster highlighting the use of the Company's Magellan™ drug discovery platform to identify allosteric inhibitors ...

The National Kidney Foundation (NKF) has awarded Jayme Locke, MD, MPH, FACS, FAST, Vice President, Medical Development, ...

Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide ...

Manchester United have confirmed plans to leave Old Trafford and move to a new 100,000-seater stadium. The new stadium, which will be the largest in the UK, will be built on club-owned land ...

M.D., Ph.D., President and Chief Executive Officer of Black Diamond Therapeutics. "Servier's commitment to innovation and deep expertise in oncology make it an ideal partner for Black Diamond as we ...

NEWARK, CALIFORNIA / ACCESS Newswire / March 18, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company"), a clinical-stage biopharmaceutical company pioneering the discovery and ...

March 18, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company ... today announced the appointment of Elizabeth M. Jaffee, M.D., to the Company's Research Advisory Board (RAB). Dr ...